Flor Munoz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Some experts have criticised Pfizer for not informing pregnant women in its trial of maternal respiratory syncytial virus vaccine that trials of a similar vaccine were halted over a potential risk of preterm birth. Others think that notification would have been premature and caused unnecessary anxiety. Hristio Boytchev reports A debate has broken out over whether Pfizer should have told pregnant women participating in its trial of maternal respiratory syncytial virus (RSV) vaccination that a trial of a similar vaccine was halted over a safety signal around preterm birth, The BMJ can report. Bo...

Pfizer and its German partner, BioNTech, said Monday that an early analysis showed their three-dose coronavirus vaccine regimen triggered a strong immune

Viral co-infection isn't new, experts say

As coronavirus cases and pediatric hospitalizations surge in the U.S., the majority of U.S. schools are staying open for in-person learning.

Now that the United States has rolled out Covid-19 booster shots for all fully vaccinated adults, some parents have been wondering if or when their vaccinated teenagers might need to